Laronix Annual Showcase (In Person)

​Laronix is a MedTech company and a leading innovator in artificial larynx devices, addressing a $21B global market for individuals who have lost or damaged their larynx (over 12 million people worldwide). Our FDA and TGA-approved devices, enhanced by artificial intelligence, deliver superior voice quality, allowing users to speak, sing, and laugh again— setting a new standard compared to outdated, robotic alternatives. Click here to learn more.

​We have launched our devices in Australia and the US, and we are now embarking on a $2M Pre-Series A round to enhance our sales efforts and accelerate growth in the US market.